Atricure Stock Investor Sentiment

ATRC Stock  USD 36.17  0.38  1.06%   
About 56% of AtriCure's investor base is looking to short. The analysis of overall sentiment of trading AtriCure stock suggests that many investors are alarmed at this time. The current market sentiment, together with AtriCure's historical and current headlines, can help investors time the market. In addition, many technical investors use AtriCure stock news signals to limit their universe of possible portfolio assets.
  

AtriCure Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards AtriCure can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
over three weeks ago at gurufocus.com         
AtriCure Inc Q3 2024 Earnings Call Highlights Strong Revenue Growth Amidst Market Challenges
Gurufocus Stories at Macroaxis
over a month ago at investing.com         
AtriCure earnings beat by 0.02, revenue topped estimates
Investing News at Macroaxis
over a month ago at gurufocus.com         
AtriCure Inc Q3 2024 Earnings Revenue Surpasses Estimates at 115. ...
Gurufocus Stories at Macroaxis
over a month ago at seekingalpha.com         
AtriCure Non-GAAP EPS of -0.17 beats by 0.03, revenue of 115.91M beats by 3.66M
seekingalpha News
over a month ago at zacks.com         
AtriCure Q3 Earnings Taking a Look at Key Metrics Versus Estimates
zacks News
over a month ago at businesswire.com         
AtriCure Reports Third Quarter 2024 Financial Results
businesswire News
over a month ago at zacks.com         
AtriCure Reports Q3 Loss, Tops Revenue Estimates
zacks News
over a month ago at gurufocus.com         
AtriCure Inc Shares Up 3.58 percent on Oct 28
Gurufocus Stories at Macroaxis
over a month ago at gurufocus.com         
AtriCure Inc Trading Down 2.91 percent on Oct 17
Gurufocus Stories at Macroaxis
over a month ago at zacks.com         
AtriCures Stock Rises After Launch of cryoSPHERE MAX Device
zacks News
over a month ago at businesswire.com         
AtriCure Announces Launch of cryoSPHERE MAX Probe for Post-Operative Pain Management
businesswire News
over a month ago at businesswire.com         
AtriCure Announces Launch of cryoSPHERE MAX Probe for Post-Operative Pain Management
businesswire News
over a month ago at massdevice.com         
AtriCure launches new CryoSphere Max cryoablation probe
news
over a month ago at finance.yahoo.com         
Shareholders in AtriCure are in the red if they invested three years ago
Yahoo News
over a month ago at finance.yahoo.com         
AtriCure Gets CE Mark for EnCompass Clamp, Expands in Europe
Yahoo News
Far too much social signal, news, headlines, and media speculation about AtriCure that are available to investors today. That information is available publicly through AtriCure media outlets and privately through word of mouth or via AtriCure internal channels. However, regardless of the origin, that massive amount of AtriCure data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of AtriCure news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of AtriCure relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to AtriCure's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive AtriCure alpha.

AtriCure Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
StockNews.com Upgrades AtriCure to Hold
09/17/2024
2
AtriCure Announces Launch of cryoSPHERE MAX Probe for Post-Operative Pain Management
10/15/2024
3
AtriCure Inc Q3 2024 Earnings Call Highlights Strong Revenue Growth Amidst Market Challenges
10/30/2024
4
AtriCure Posts Earnings Results
10/31/2024
5
US42.67 - Thats What Analysts Think AtriCure, Inc. Is Worth After These Results
11/01/2024
6
AtriCure Stock Surges Over 5 percent Amid Market Volatility
11/05/2024
7
Stocks With Rising Relative Price Strength AtriCure
11/06/2024
8
AtriCure Inc Stock Price Down 3.06 percent on Nov 12
11/12/2024
9
Az ATRC VentureOne a kvantumkorszak adatbiztonsgnak rdekben elindtja a QuantumGate-et a CyberQ-nl
11/14/2024
10
Disposition of 4417 shares by Dahlquist Karl S. of AtriCure at 44.83 subject to Rule 16b-3
11/15/2024

Complementary Tools for AtriCure Stock analysis

When running AtriCure's price analysis, check to measure AtriCure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AtriCure is operating at the current time. Most of AtriCure's value examination focuses on studying past and present price action to predict the probability of AtriCure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AtriCure's price. Additionally, you may evaluate how the addition of AtriCure to your portfolios can decrease your overall portfolio volatility.
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules